Skip to main content
SpringerLink
Log in

Renal Calculi

  • Chapter
  • First Online:
Pediatric Kidney Disease

Abstract

Although still a relatively uncommon disease in children, urolithiasis is increasing in frequency, and is associated with significant morbidity. Infants and children are more likely to have an underlying etiology for stones, including inherited errors of metabolism and anatomic abnormalities of the urinary tract. A systematic approach is required to detect those disorders, which, if left untreated, have a high propensity to result in a long term reduction in renal function.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Novak TE, Lakshmanan Y, Trock BJ, Gearhart JP, Matlaga BR. Sex prevalence of pediatric kidney stone disease in the United States: an epidemiologic investigation. Urology. 2009;74(1):104–7.

    Article  PubMed  Google Scholar 

  2. Sas DJ, Hulsey TC, Shatat IF, Orak JK. Increasing incidence of kidney stones in children evaluated in the emergency department. J Pediatr. 2010;157(1):132–7.

    Article  PubMed  Google Scholar 

  3. Valentini RP, Lakshmanan Y. Nephrolithiasis in children. Adv Chronic Kidney Dis. 2011;18(5):370–5.

    Article  PubMed  Google Scholar 

  4. VanDervoort K, Wiesen J, Frank R, Vento S, Crosby V, Chandra M, et al. Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome. J Urol. 2007;177(6):2300–5.

    Article  PubMed  Google Scholar 

  5. Alpay H, Ozen A, Gokce I, Biyikli N. Clinical and metabolic features of urolithiasis and microlithiasis in children. Pediatr Nephrol. 2009;24(11):2203–9.

    Article  PubMed  Google Scholar 

  6. Habbig S, Beck BB, Hoppe B. Nephrocalcinosis and urolithiasis in children. Kidney Int. 2011;80(12):1278–91.

    Article  PubMed  Google Scholar 

  7. Le JD, Eisner BH, Tseng TY, Chi T, Stoller ML. Laterality of nephrocalcinosis in kidney stone formers with severe hypocitraturia. BJU Int. 2011;107(1):106–10.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Lopez M, Hoppe B. History, epidemiology and regional diversities of urolithiasis. Pediatr Nephrol. 2010;25(1):49–59.

    Article  PubMed  Google Scholar 

  9. Asselman M, Verhulst A, De Broe ME, Verkoelen CF. Calcium oxalate crystal adherence to hyaluronan-, osteopontin-, and CD44-expressing injured/regenerating tubular epithelial cells in rat kidneys. J Am Soc Nephrol. 2003;14(12):3155–66.

    Article  CAS  PubMed  Google Scholar 

  10. Shumer T, Taylor W. Severe hypercalcaemia due to subcutaneous fat necrosis: presentation, management and complications. Arch Dis Child Fetal Neonatal Ed. 2014;99:F419–21.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Rejnmark L, Vestergaard P, Mosekilde L. Nephrolithiasis and renal calcifications in primary hyperparathyroidism. J Clin Endocrinol Metab. 2011;96(8):2377–85.

    Article  CAS  PubMed  Google Scholar 

  12. Suh JM, Cronan JJ, Monchik JM. Primary hyperparathyroidism: is there an increased prevalence of renal stone disease? AJR Am J Roentgenol. 2008;191(3):908–11.

    Article  PubMed  Google Scholar 

  13. Tiselius HG. Epidemiology and medical management of stone disease. BJU Int. 2003;91(8):758–67.

    Article  PubMed  Google Scholar 

  14. Grases F, Sohnel O, Costa-Bauza A. Renal stone formation and development. Int Urol Nephrol. 1999;31(5):591–600.

    Article  CAS  PubMed  Google Scholar 

  15. Vella M, Karydi M, Coraci G, Oriti R, Melloni D. Pathophysiology and clinical aspects of urinary lithiasis. Urol Int. 2007;79 Suppl 1:26–31.

    Article  PubMed  Google Scholar 

  16. Fasano JM, Khan SR. Intratubular crystallization of calcium oxalate in the presence of membrane vesicles: an in vitro study. Kidney Int. 2001;59(1):169–78.

    Article  CAS  PubMed  Google Scholar 

  17. Khan SR, Shevock PN, Hackett RL. Membrane-associated crystallization of calcium oxalate in vitro. Calcif Tissue Int. 1990;46(2):116–20.

    Article  CAS  PubMed  Google Scholar 

  18. Finlayson B, Khan SR, Hackett RL. Mechanisms of stone formation – an overview. Scan Electron Microsc. 1984;(Pt 3):1419–25.

    Google Scholar 

  19. Evan AP. Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol. 2010;25(5):831–41.

    Article  PubMed  Google Scholar 

  20. Randall A. The origin and growth of renal calculi. Ann Surg. 1937;105(6):1009–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Momohara C, Tsujihata M, Yoshioka I, Tsujimura A, Nonomura N, Okuyama A. Mechanism underlying the low prevalence of pediatric calcium oxalate urolithiasis. J Urol. 2009;182(3):1201–9.

    Article  CAS  PubMed  Google Scholar 

  22. Copelovitch L. Urolithiasis in children: medical approach. Pediatr Clin N Am. 2012;59(4):881–96.

    Article  Google Scholar 

  23. Hoppe B, Kemper MJ. Diagnostic examination of the child with urolithiasis or nephrocalcinosis. Pediatr Nephrol. 2010;25(3):403–13.

    Article  PubMed  Google Scholar 

  24. Ferraro PM, Taylor EN, Gambaro G, Curhan GC. Soda and other beverages and the risk of kidney stones. Clin J Am Soc Nephrol. 2013;8(8):1389–95.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Eisner BH, Reese A, Sheth S, Stoller ML. Ureteral stone location at emergency room presentation with colic. J Urol. 2009;182(1):165–8.

    Article  PubMed  Google Scholar 

  26. Sung MK, Singh S, Kalra MK. Current status of low dose multi-detector CT in the urinary tract. World J Radiol. 2011;3(11):256–65.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Sandhu C, Anson KM, Patel U. Urinary tract stones – Part I: role of radiological imaging in diagnosis and treatment planning. Clin Radiol. 2003;58(6):415–21.

    Article  CAS  PubMed  Google Scholar 

  28. Werness PG, Brown CM, Smith LH, Finlayson B. EQUIL2: a BASIC computer program for the calculation of urinary saturation. J Urol. 1985;134(6):1242–4.

    CAS  PubMed  Google Scholar 

  29. Porowski T, Konstantynowicz J, Zoch-Zwierz W, Kirejczyk JK, Taranta-Janusz K, Korzeniecka-Kozerska A. Spontaneous urinary calcium oxalate crystallization in hypercalciuric children. Pediatr Nephrol. 2009;24(9):1705–10.

    Article  PubMed  Google Scholar 

  30. Porowski T, Zoch-Zwierz W, Konstantynowicz J, Taranta-Janusz K. A new approach to the diagnosis of children’s urolithiasis based on the Bonn Risk Index. Pediatr Nephrol. 2008;23(7):1123–8.

    Article  PubMed  Google Scholar 

  31. Porowski T, Mrozek P, Sidun J, Zoch-Zwierz W, Konstantynowicz J, Kirejczyk JK, et al. Bonn Risk Index based micromethod for assessing risk of urinary calcium oxalate stone formation. J Urol. 2010;183(3):1157–62.

    Article  CAS  PubMed  Google Scholar 

  32. Mir S, Serdaroglu E. Quantification of hypercalciuria with the urine calcium osmolality ratio in children. Pediatr Nephrol. 2005;20(11):1562–5.

    Article  PubMed  Google Scholar 

  33. Richmond W, Colgan G, Simon S, Stuart-Hilgenfeld M, Wilson N, Alon US. Random urine calcium/osmolality in the assessment of calciuria in children with decreased muscle mass. Clin Nephrol. 2005;64(4):264–70.

    Article  CAS  PubMed  Google Scholar 

  34. Touitou Y, Auzeby A, Camus F, Djeridane Y. Twenty-four-hour profiles of urinary excretion of calcium, magnesium, phosphorus, urea, and creatinine in healthy prepubertal boys. Clin Biochem. 2010;43(1–2):102–5.

    Article  CAS  PubMed  Google Scholar 

  35. Matos V, Van Melle G, Werner D, Bardy D, Guignard JP. Urinary oxalate and urate to creatinine ratios in a healthy pediatric population. Am J Kidney Dis. 1999;34(2):e1.

    Article  CAS  PubMed  Google Scholar 

  36. Kirejczyk JK, Porowski T, Konstantynowicz J, Kozerska A, Nazarkiewicz A, Hoppe B, et al. Urinary citrate excretion in healthy children depends on age and gender. Pediatr Nephrol. 2014;29(9):1575–82.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Srivastava T, Winston MJ, Auron A, Alon US. Urine calcium/citrate ratio in children with hypercalciuric stones. Pediatr Res. 2009;66(1):85–90.

    Article  CAS  PubMed  Google Scholar 

  38. Arrabal-Polo MA, Arrabal-Martin M, Arias-Santiago S, Garrido-Gomez J, Poyatos-Andujar A, Zuluaga-Gomez A. Importance of citrate and the calcium: citrate ratio in patients with calcium renal lithiasis and severe lithogenesis. BJU Int. 2013;111(4):622–7.

    Article  CAS  PubMed  Google Scholar 

  39. Ferraro PM, D’Addessi A, Gambaro G. When to suspect a genetic disorder in a patient with renal stones, and why. Nephrol Dial Transplant. 2013;28(4):811–20.

    Article  CAS  PubMed  Google Scholar 

  40. Edvardsson VO, Goldfarb DS, Lieske JC, Beara-Lasic L, Anglani F, Milliner DS, et al. Hereditary causes of kidney stones and chronic kidney disease. Pediatr Nephrol. 2013;28(10):1923–42.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Monico CG, Milliner DS. Genetic determinants of urolithiasis. Nat Rev Nephrol. 2011;8(3):151–62.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  42. Stechman MJ, Loh NY, Thakker RV. Genetic causes of hypercalciuric nephrolithiasis. Pediatr Nephrol. 2009;24(12):2321–32.

    Article  PubMed  Google Scholar 

  43. Tasian GE, Ziemba J, Casale P. Unilateral hypercalciuria: a stealth culprit in recurrent ipsilateral urolithiasis in children. J Urol. 2012;188(6):2330–5.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Schwaderer AL, Cronin R, Mahan JD, Bates CM. Low bone density in children with hypercalciuria and/or nephrolithiasis. Pediatr Nephrol. 2008;23(12):2209–14.

    Article  PubMed  Google Scholar 

  45. Audran M, Legrand E. Hypercalciuria. Joint Bone Spine. 2000;67(6):509–15.

    Article  CAS  PubMed  Google Scholar 

  46. Levy FL, Adams-Huet B, Pak CY. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med. 1995;98(1):50–9.

    Article  CAS  PubMed  Google Scholar 

  47. Gambaro G, Vezzoli G, Casari G, Rampoldi L, D’Angelo A, Borghi L. Genetics of hypercalciuria and calcium nephrolithiasis: from the rare monogenic to the common polygenic forms. Am J Kidney Dis. 2004;44(6):963–86.

    Article  CAS  PubMed  Google Scholar 

  48. Vezzoli G, Terranegra A, Arcidiacono T, Soldati L. Genetics and calcium nephrolithiasis. Kidney Int. 2011;80(6):587–93.

    Article  CAS  PubMed  Google Scholar 

  49. Bergsland KJ, Coe FL, White MD, Erhard MJ, DeFoor WR, Mahan JD, et al. Urine risk factors in children with calcium kidney stones and their siblings. Kidney Int. 2012;81(11):1140–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Penido MG, Lima EM, Marino VS, Tupinamba AL, Franca A, Souto MF. Bone alterations in children with idiopathic hypercalciuria at the time of diagnosis. Pediatr Nephrol. 2003;18(2):133–9.

    PubMed  Google Scholar 

  51. Miller LA, Noe HN, Stapleton FB. Uric acid excretion in children with urolithiasis. J Pediatr. 1989;115(6):923–6.

    Article  CAS  PubMed  Google Scholar 

  52. Schlingmann KP, Kaufmann M, Weber S, Irwin A, Goos C, John U, et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med. 2011;365(5):410–21.

    Article  CAS  PubMed  Google Scholar 

  53. Jacobs TP, Kaufman M, Jones G, Kumar R, Schlingmann KP, Shapses S, et al. A lifetime of hypercalcemia and hypercalciuria, finally explained. J Clin Endocrinol Metab. 2014;99(3):708–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Sayers J, Hynes AM, Rice SJ, Hogg P, Sayer JA. Searching for CYP24A1 mutations in cohorts of patients with calcium nephrolithiasis. OA Nephrol. 2013;1(1):6.

    Google Scholar 

  55. Knohl SJ, Scheinman SJ. Inherited hypercalciuric syndromes: Dent’s disease (CLC-5) and familial hypomagnesemia with hypercalciuria (paracellin-1). Semin Nephrol. 2004;24(1):55–60.

    Article  PubMed  Google Scholar 

  56. Claverie-Martin F, Ramos-Trujillo E, Garcia-Nieto V. Dent’s disease: clinical features and molecular basis. Pediatr Nephrol. 2011;26(5):693–704.

    Article  PubMed  Google Scholar 

  57. Alexander RT, Hoenderop JG, Bindels RJ. Molecular determinants of magnesium homeostasis: insights from human disease. J Am Soc Nephrol. 2008;19(8):1451–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Angelow S, Ahlstrom R, Yu AS. Biology of claudins. Am J Physiol Ren Physiol. 2008;295(4):F867–76.

    Article  CAS  Google Scholar 

  59. Benigno V, Canonica CS, Bettinelli A, von Vigier RO, Truttmann AC, Bianchetti MG. Hypomagnesaemia-hypercalciuria-nephrocalcinosis: a report of nine cases and a review. Nephrol Dial Transplant. 2000;15(5):605–10.

    Article  CAS  PubMed  Google Scholar 

  60. Hou J, Goodenough DA. Claudin-16 and claudin-19 function in the thick ascending limb. Curr Opin Nephrol Hypertens. 2010;19(5):483–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Li J, Ananthapanyasut W, Yu AS. Claudins in renal physiology and disease. Pediatr Nephrol. 2011;26(12):2133–42.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Agus ZS. Hypomagnesemia. J Am Soc Nephrol. 1999;10(7):1616–22.

    CAS  PubMed  Google Scholar 

  63. Matos V, van Melle G, Boulat O, Markert M, Bachmann C, Guignard JP. Urinary phosphate/creatinine, calcium/creatinine, and magnesium/creatinine ratios in a healthy pediatric population. J Pediatr. 1997;131(2):252–7.

    Article  CAS  PubMed  Google Scholar 

  64. Ghazali S, Barratt TM. Urinary excretion of calcium and magnesium in children. Arch Dis Child. 1974;49(2):97–101.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Saez-Torres C, Rodrigo D, Grases F, Garcia-Raja AM, Gomez C, Lumbreras J, et al. Urinary excretion of calcium, magnesium, phosphate, citrate, oxalate, and uric acid by healthy schoolchildren using a 12-h collection protocol. Pediatr Nephrol. 2014;29(7):1201–8.

    Article  PubMed  Google Scholar 

  66. Hou J, Rajagopal M, Yu AS. Claudins and the kidney. Annu Rev Physiol. 2013;75:479–501.

    Article  CAS  PubMed  Google Scholar 

  67. Li SL, Liou LB, Fang JT, Tsai WP. Symptomatic renal tubular acidosis (RTA) in patients with systemic lupus erythematosus: an analysis of six cases with new association of type 4 RTA. Rheumatology (Oxford). 2005;44(9):1176–80.

    Article  CAS  Google Scholar 

  68. Nicoletta JA, Schwartz GJ. Distal renal tubular acidosis. Curr Opin Pediatr. 2004;16(2):194–8.

    Article  PubMed  Google Scholar 

  69. Tsai HY, Lin SH, Lin CC, Huang FY, Lee MD, Tsai JD. Why is hypercalciuria absent at diagnosis in some children with ATP6V1B1 mutation? Pediatr Nephrol. 2011;26(10):1903–7.

    Article  PubMed  Google Scholar 

  70. Laing CM, Toye AM, Capasso G, Unwin RJ. Renal tubular acidosis: developments in our understanding of the molecular basis. Int J Biochem Cell Biol. 2005;37(6):1151–61.

    Article  CAS  PubMed  Google Scholar 

  71. Stiburkova B, Bleyer AJ. Changes in serum urate and urate excretion with age. Adv Chronic Kidney Dis. 2012;19(6):372–6.

    Article  PubMed  Google Scholar 

  72. Stapleton FB, Linshaw MA, Hassanein K, Gruskin AB. Uric acid excretion in normal children. J Pediatr. 1978;92(6):911–4.

    Article  CAS  PubMed  Google Scholar 

  73. Kaya M, Boleken ME, Soran M, Kanmaz T, Yucesan S. Acute renal failure due to bilateral uric acid lithiasis in infants. Urol Res. 2007;35(3):119–22.

    Article  PubMed  Google Scholar 

  74. Sebesta I. Genetic disorders resulting in hyper- or hypouricemia. Adv Chronic Kidney Dis. 2012;19(6):398–403.

    Article  PubMed  Google Scholar 

  75. Jinnah HA. Lesch-Nyhan disease: from mechanism to model and back again. Dis Model Mech. 2009;2(3–4):116–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Sebesta I, Stiburkova B. Purine disorders with hypouricemia. Prilozi/Makedonska akademija na naukite i umetnostite, Oddelenie za bioloski i medicinski nauki = Contributions/Macedonian Academy of Sciences and Arts. Sect Biol Med Sci. 2014;35(1):87–92.

    Google Scholar 

  77. Ichida K, Yoshida M, Sakuma R, Hosoya T. Two siblings with classical xanthinuria type 1: significance of allopurinol loading test. Intern Med. 1998;37(1):77–82.

    Article  CAS  PubMed  Google Scholar 

  78. Stiburkova B, Taylor J, Marinaki AM, Sebesta I. Acute kidney injury in two children caused by renal hypouricaemia type 2. Pediatr Nephrol. 2012;27(8):1411–5.

    Article  PubMed  Google Scholar 

  79. Tasic V, Hynes AM, Kitamura K, Cheong HI, Lozanovski VJ, Gucev Z, et al. Clinical and functional characterization of URAT1 variants. PLoS One. 2011;6(12):e28641.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Marra G, Vercelloni PG, Edefonti A, Manzoni G, Pavesi MA, Fogazzi GB, et al. Adenine phosphoribosyltransferase deficiency: an underdiagnosed cause of lithiasis and renal failure. JIMD Rep. 2012;5:45–8.

    Article  PubMed  Google Scholar 

  81. Harambat J, Bollee G, Daudon M, Ceballos-Picot I, Bensman A. Adenine phosphoribosyltransferase deficiency in children. Pediatr Nephrol. 2012;27(4):571–9.

    Article  PubMed  Google Scholar 

  82. Dahan K, Devuyst O, Smaers M, Vertommen D, Loute G, Poux JM, et al. A cluster of mutations in the UMOD gene causes familial juvenile hyperuricemic nephropathy with abnormal expression of uromodulin. J Am Soc Nephrol. 2003;14(11):2883–93.

    Article  CAS  PubMed  Google Scholar 

  83. Milliner DS. The primary hyperoxalurias: an algorithm for diagnosis. Am J Nephrol. 2005;25(2):154–60.

    Article  PubMed  Google Scholar 

  84. Cochat P, Hulton SA, Acquaviva C, Danpure CJ, Daudon M, De Marchi M, et al. Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment. Nephrol Dial Transplant. 2012;27(5):1729–36.

    Article  CAS  PubMed  Google Scholar 

  85. Cochat P, Rumsby G. Primary hyperoxaluria. N Engl J Med. 2013;369(7):649–58.

    Article  CAS  PubMed  Google Scholar 

  86. Truong LD, Yakupoglu U, Feig D, Hicks J, Cartwight J, Sheikh-Hamad D, et al. Calcium oxalate deposition in renal allografts: morphologic spectrum and clinical implications. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2004;4(8):1338–44.

    Article  Google Scholar 

  87. Sumorok N, Goldfarb DS. Update on cystinuria. Curr Opin Nephrol Hypertens. 2013;22(4):427–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Saravakos P, Kokkinou V, Giannatos E. Cystinuria: current diagnosis and management. Urology. 2014;83(4):693–9.

    Article  PubMed  Google Scholar 

  89. Chillaron J, Font-Llitjos M, Fort J, Zorzano A, Goldfarb DS, Nunes V, et al. Pathophysiology and treatment of cystinuria. Nat Rev Nephrol. 2010;6(7):424–34.

    Article  CAS  PubMed  Google Scholar 

  90. Biyani C, Cartledge J. Cystinuria-diagnosis and management. EAU-EBU Updat Ser. 2006;4:175–83.

    Article  Google Scholar 

  91. Elkoushy MA, Andonian S. Characterization of patients with heterozygous cystinuria. Urology. 2012;80(4):795–9.

    Article  PubMed  Google Scholar 

  92. Claes DJ, Jackson E. Cystinuria: mechanisms and management. Pediatr Nephrol. 2012;27(11):2031–8.

    Article  PubMed  Google Scholar 

  93. Cochat P, Pichault V, Bacchetta J, Dubourg L, Sabot JF, Saban C, et al. Nephrolithiasis related to inborn metabolic diseases. Pediatr Nephrol. 2010;25(3):415–24.

    Article  PubMed  Google Scholar 

  94. Pahari A, Milla PJ, van’t Hoff WG. Neonatal nephrocalcinosis in association with glucose-galactose malabsorption. Pediatr Nephrol. 2003;18(7):700–2.

    PubMed  Google Scholar 

  95. Saarela T, Simila S, Koivisto M. Hypercalcemia and nephrocalcinosis in patients with congenital lactase deficiency. J Pediatr. 1995;127(6):920–3.

    Article  CAS  PubMed  Google Scholar 

  96. Laube GF, Leonard JV, van’t Hoff WG. Nephrocalcinosis and medullary cysts in 3-methylglutaconic aciduria. Pediatr Nephrol. 2003;18(7):712–3.

    PubMed  Google Scholar 

  97. Fabris A, Anglani F, Lupo A, Gambaro G. Medullary sponge kidney: state of the art. Nephrol Dial Transplant. 2013;28(5):1111–9.

    Article  PubMed  Google Scholar 

  98. Fabris A, Bernich P, Abaterusso C, Marchionna N, Canciani C, Nouvenne A, et al. Bone disease in medullary sponge kidney and effect of potassium citrate treatment. Clin J Am Soc Nephrol. 2009;4(12):1974–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Fabris A, Lupo A, Bernich P, Abaterusso C, Marchionna N, Nouvenne A, et al. Long-term treatment with potassium citrate and renal stones in medullary sponge kidney. Clin J Am Soc Nephrol. 2010;5(9):1663–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  100. Hau AK, Kwan TH, Li PK. Melamine toxicity and the kidney. J Am Soc Nephrol. 2009;20(2):245–50.

    Article  CAS  PubMed  Google Scholar 

  101. Ingelfinger JR. Melamine and the global implications of food contamination. N Engl J Med. 2008;359(26):2745–8.

    Article  CAS  PubMed  Google Scholar 

  102. Parry J. China's tainted milk scandal spreads around world. BMJ. 2008;337:a1890.

    Article  PubMed  Google Scholar 

  103. Wang IJ, Chen PC, Hwang KC. Melamine and nephrolithiasis in children in Taiwan. N Engl J Med. 2009;360(11):1157–8.

    Article  CAS  PubMed  Google Scholar 

  104. Sun Q, Shen Y, Sun N, Zhang GJ, Chen Z, Fan JF, et al. Diagnosis, treatment and follow-up of 25 patients with melamine-induced kidney stones complicated by acute obstructive renal failure in Beijing Children’s Hospital. Eur J Pediatr. 2010;169(4):483–9.

    Article  PubMed  Google Scholar 

  105. Wen JG, Li ZZ, Zhang H, Wang Y, Zhang RF, Yang L, et al. Melamine related bilateral renal calculi in 50 children: single center experience in clinical diagnosis and treatment. J Urol. 2010;183(4):1533–7.

    Article  PubMed  Google Scholar 

  106. Wen JG, Chang QL, Lou AF, Li ZZ, Lu S, Wang Y, et al. Melamine-related urinary stones in 195 infants and young children: clinical features within 2 years of follow-up. Urol Int. 2011;87(4):429–33.

    Article  CAS  PubMed  Google Scholar 

  107. Yang L, Wen JG, Wen JJ, Su ZQ, Zhu W, Huang CX, et al. Four years follow-up of 101 children with melamine-related urinary stones. Urolithiasis. 2013;41(3):265–6.

    Article  CAS  PubMed  Google Scholar 

  108. Yoshida O, Okada Y. Epidemiology of urolithiasis in Japan: a chronological and geographical study. Urol Int. 1990;45(2):104–11.

    Article  CAS  PubMed  Google Scholar 

  109. Gargollo PC, Paltiel HJ, Rosoklija I, Diamond DA. Mound calcification after endoscopic treatment of vesicoureteral reflux with autologous chondrocytes – a normal variant of mound appearance? J Urol. 2009;181(6):2702–7; discussion 7–8.

    Article  PubMed  Google Scholar 

  110. Schwartz BF, Stoller ML. The vesical calculus. Urol Clin N Am. 2000;27(2):333–46.

    Article  CAS  Google Scholar 

  111. Kispal Z, Balogh D, Erdei O, Kehl D, Juhasz Z, Vastyan AM, et al. Complications after bladder augmentation or substitution in children: a prospective study of 86 patients. BJU Int. 2011;108(2):282–9.

    Article  PubMed  Google Scholar 

  112. Khoury AE, Salomon M, Doche R, Soboh F, Ackerley C, Jayanthi R, et al. Stone formation after augmentation cystoplasty: the role of intestinal mucus. J Urol. 1997;158(3 Pt 2):1133–7.

    CAS  PubMed  Google Scholar 

  113. Al-Marhoon MS, Sarhan OM, Awad BA, Helmy T, Ghali A, Dawaba MS. Comparison of endourological and open cystolithotomy in the management of bladder stones in children. J Urol. 2009;181(6):2684–7; discussion 7–8.

    Article  PubMed  Google Scholar 

  114. Abrahams HM, Stoller ML. Infection and urinary stones. Curr Opin Urol. 2003;13(1):63–7.

    Article  PubMed  Google Scholar 

  115. Preminger GM, Assimos DG, Lingeman JE, Nakada SY, Pearle MS, Wolf Jr JS, et al. Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J Urol. 2005;173(6):1991–2000.

    Article  PubMed  Google Scholar 

  116. Wroe S. Zonisamide and renal calculi in patients with epilepsy: how big an issue? Curr Med Res Opin. 2007;23(8):1765–73.

    Article  CAS  PubMed  Google Scholar 

  117. Mirza N, Marson AG, Pirmohamed M. Effect of topiramate on acid-base balance: extent, mechanism and effects. Br J Clin Pharmacol. 2009;68(5):655–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  118. Goyal M, Grossberg RI, O'Riordan MA, Davis ID. Urolithiasis with topiramate in nonambulatory children and young adults. Pediatr Neurol. 2009;40(4):289–94.

    Article  PubMed  Google Scholar 

  119. Kossoff EH, Wang HS. Dietary therapies for epilepsy. Biomed J. 2013;36(1):2–8.

    Article  PubMed  Google Scholar 

  120. Groesbeck DK, Bluml RM, Kossoff EH. Long-term use of the ketogenic diet in the treatment of epilepsy. Dev Med Child Neurol. 2006;48(12):978–81.

    Article  PubMed  Google Scholar 

  121. Sampath A, Kossoff EH, Furth SL, Pyzik PL, Vining EP. Kidney stones and the ketogenic diet: risk factors and prevention. J Child Neurol. 2007;22(4):375–8.

    Article  PubMed  Google Scholar 

  122. McNally MA, Pyzik PL, Rubenstein JE, Hamdy RF, Kossoff EH. Empiric use of potassium citrate reduces kidney-stone incidence with the ketogenic diet. Pediatrics. 2009;124(2):e300–4.

    Article  PubMed  Google Scholar 

  123. Heher EC, Thier SO, Rennke H, Humphreys BD. Adverse renal and metabolic effects associated with oral sodium phosphate bowel preparation. Clin J Am Soc Nephrol. 2008;3(5):1494–503.

    Article  PubMed  PubMed Central  Google Scholar 

  124. Ehrenpreis ED, Parakkal D, Semer R, Du H. Renal risks of sodium phosphate tablets for colonoscopy preparation: a review of adverse drug reactions reported to the US Food and Drug Administration. Color Dis. 2011;13(9):e270–5.

    Article  CAS  Google Scholar 

  125. Lien YH. Is bowel preparation before colonoscopy a risky business for the kidney? Nat Clin Pract Nephrol. 2008;4(11):606–14.

    Article  PubMed  Google Scholar 

  126. Rausch HP, Hanefeld F, Kaufmann HJ. Medullary nephrocalcinosis and pancreatic calcifications demonstrated by ultrasound and CT in infants after treatment with ACTH. Radiology. 1984;153(1):105–7.

    Article  CAS  PubMed  Google Scholar 

  127. Riikonen R, Simell O, Jaaskelainen J, Rapola J, Perheentupa J. Disturbed calcium and phosphate homeostasis during treatment with ACTH of infantile spasms. Arch Dis Child. 1986;61(7):671–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  128. Greenberg A. Diuretic complications. Am J Med Sci. 2000;319(1):10–24.

    Article  CAS  PubMed  Google Scholar 

  129. Sorgel F, Ettinger B, Benet LZ. The true composition of kidney stones passed during triamterene therapy. J Urol. 1985;134(5):871–3.

    CAS  PubMed  Google Scholar 

  130. Stojanovic V, Djuric Vijatov G. Nephrolithiasis caused by ceftriaxone in a 3-year-old child with ureteropelvic junction obstruction. Case Rep Medic. 2009;2009:365962.

    Google Scholar 

  131. Stapenhorst L, Sassen R, Beck B, Laube N, Hesse A, Hoppe B. Hypocitraturia as a risk factor for nephrocalcinosis after kidney transplantation. Pediatr Nephrol. 2005;20(5):652–6.

    Article  PubMed  Google Scholar 

  132. Khositseth S, Gillingham KJ, Cook ME, Chavers BM. Urolithiasis after kidney transplantation in pediatric recipients: a single center report. Transplantation. 2004;78(9):1319–23.

    Article  PubMed  Google Scholar 

  133. Catalano-Pons C, Bargy S, Schlecht D, Tabone MD, Deschenes G, Bensman A, et al. Sulfadiazine-induced nephrolithiasis in children. Pediatr Nephrol. 2004;19(8):928–31.

    Article  PubMed  Google Scholar 

  134. Joy HM, Fairhurst JJ, Beattie RM. Renal calculus at presentation in a child with Crohn’s disease. Pediatr Radiol. 2003;33(4):250–2.

    Article  PubMed  Google Scholar 

  135. Schell-Feith EA, Kist-van Holthe JE, van der Heijden AJ. Nephrocalcinosis in preterm neonates. Pediatr Nephrol. 2010;25(2):221–30.

    Article  PubMed  Google Scholar 

  136. Schell-Feith EA, Moerdijk A, van Zwieten PH, Zonderland HM, Holscher HC, Kist-van Holthe J, et al. Does citrate prevent nephrocalcinosis in preterm neonates? Pediatr Nephrol. 2006;21(12):1830–6.

    Article  PubMed  Google Scholar 

  137. Szymanski KM, Misseri R, Whittam B, Amstutz S, Kaefer M, Rink RC, et al. Cutting for stone in augmented bladders-what is the risk of recurrence and is it impacted by treatment modality? J Urol. 2014;191(5):1375–80.

    Article  PubMed  Google Scholar 

  138. Howard SC, Kaplan SD, Razzouk BI, Rivera GK, Sandlund JT, Ribeiro RC, et al. Urolithiasis in pediatric patients with acute lymphoblastic leukemia. Leukemia. 2003;17(3):541–6.

    Article  CAS  PubMed  Google Scholar 

  139. Hoffmeister PA, Storer BE, Baker KS, Hingorani SR. Nephrolithiasis in pediatric hematopoietic cell transplantation with up to 40 years of follow-up. Pediatr Blood Cancer. 2014;61(3):417–23.

    Article  PubMed  Google Scholar 

  140. Kaste SC, Thomas NA, Rai SN, Cheon K, McCammon E, Chesney R, et al. Asymptomatic kidney stones in long-term survivors of childhood acute lymphoblastic leukemia. Leukemia. 2009;23(1):104–8.

    Article  CAS  PubMed  Google Scholar 

  141. Saez-Torres C, Grases F, Rodrigo D, Garcia-Raja AM, Gomez C, Frontera G. Risk factors for urinary stones in healthy schoolchildren with and without a family history of nephrolithiasis. Pediatr Nephrol. 2013;28(4):639–45.

    Article  PubMed  Google Scholar 

  142. de Boer H, Roelofsen A, Janssens PM. Antidiuretic hormone antagonist to reduce cystine stone formation. Ann Intern Med. 2012;157(6):459–60.

    Article  PubMed  Google Scholar 

  143. Sarica K. Pediatric urolithiasis: etiology, specific pathogenesis and medical treatment. Urol Res. 2006;34(2):96–101.

    Article  CAS  PubMed  Google Scholar 

  144. Izol V, Aridogan IA, Karsli O, Deger M, Satar N. The effect of prophylactic treatment with Shohl’s solution in children with cystinuria. J Pediatr Urol. 2013;9(6):1218–22.

    Article  PubMed  Google Scholar 

  145. Sterrett SP, Penniston KL, Wolf Jr JS, Nakada SY. Acetazolamide is an effective adjunct for urinary alkalization in patients with uric acid and cystine stone formation recalcitrant to potassium citrate. Urology. 2008;72(2):278–81.

    Article  PubMed  Google Scholar 

  146. Tekin A, Tekgul S, Atsu N, Bakkaloglu M, Kendi S. Oral potassium citrate treatment for idiopathic hypocitruria in children with calcium urolithiasis. J Urol. 2002;168(6):2572–4.

    Article  CAS  PubMed  Google Scholar 

  147. Escribano J, Balaguer A, Pagone F, Feliu A, Roque IFM. Pharmacological interventions for preventing complications in idiopathic hypercalciuria. Cochrane Database Syst Rev. 2009;1:CD004754.

    Google Scholar 

  148. DeBerardinis RJ, Coughlin 2nd CR, Kaplan P. Penicillamine therapy for pediatric cystinuria: experience from a cohort of American children. J Urol. 2008;180(6):2620–3.

    Article  PubMed  PubMed Central  Google Scholar 

  149. Dello Strologo L, Laurenzi C, Legato A, Pastore A. Cystinuria in children and young adults: success of monitoring free-cystine urine levels. Pediatr Nephrol. 2007;22(11):1869–73.

    Article  PubMed  Google Scholar 

  150. Worcester EM, Coe FL, Evan AP, Parks JH. Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis. BJU Int. 2006;97(6):1285–90.

    Article  CAS  PubMed  Google Scholar 

  151. Coe FL, Asplin JR. Medicine. Stopping the stones. Science (New York, NY). 2010;330(6002):325–6.

    Article  CAS  Google Scholar 

  152. Rimer JD, An Z, Zhu Z, Lee MH, Goldfarb DS, Wesson JA, et al. Crystal growth inhibitors for the prevention of L-cystine kidney stones through molecular design. Science (New York, NY). 2010;330(6002):337–41.

    Article  CAS  Google Scholar 

  153. Raja KA, Schurman S, D'Mello RG, Blowey D, Goodyer P, Van Why S, et al. Responsiveness of hypercalciuria to thiazide in Dent’s disease. J Am Soc Nephrol. 2002;13(12):2938–44.

    Article  PubMed  Google Scholar 

  154. Torres RJ, Prior C, Puig JG. Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency. Metabolism. 2007;56(9):1179–86.

    Article  CAS  PubMed  Google Scholar 

  155. Mokhless I, Zahran AR, Youssif M, Fahmy A. Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study. J Pediatr Urol. 2012;8(5):544–8.

    Article  PubMed  Google Scholar 

  156. Zheng S, Liu LR, Yuan HC, Wei Q. Tamsulosin as adjunctive treatment after shockwave lithotripsy in patients with upper urinary tract stones: a systematic review and meta-analysis. Scand J Urol Nephrol. 2010;44(6):425–32.

    Article  CAS  PubMed  Google Scholar 

  157. Oh MM, Ham BK, Kang SH, Bae JH, Kim JJ, Yoo KH, et al. Urine alkalinization may be enough for the treatment of bilateral renal pelvis stones associated with Lesch-Nyhan syndrome. Urol Res. 2011;39(5):417–9.

    Article  PubMed  Google Scholar 

  158. Kim SS, Kolon TF, Canter D, White M, Casale P. Pediatric flexible ureteroscopic lithotripsy: the children’s hospital of Philadelphia experience. J Urol. 2008;180(6):2616–9; discussion 9.

    Article  PubMed  Google Scholar 

  159. Griffin SJ, Margaryan M, Archambaud F, Sergent-Alaoui A, Lottmann HB. Safety of shock wave lithotripsy for treatment of pediatric urolithiasis: 20-year experience. J Urol. 2010;183(6):2332–6.

    Article  PubMed  Google Scholar 

  160. Fayad A, El-Sheikh MG, Abdelmohsen M, Abdelraouf H. Evaluation of renal function in children undergoing extracorporeal shock wave lithotripsy. J Urol. 2010;184(3):1111–4.

    Article  CAS  PubMed  Google Scholar 

  161. McAdams S, Kim N, Ravish IR, Monga M, Ugarte R, Nerli R, et al. Stone size is only independent predictor of shock wave lithotripsy success in children: a community experience. J Urol. 2010;184(2):659–64.

    Article  PubMed  Google Scholar 

  162. Elsobky E, Sheir KZ, Madbouly K, Mokhtar AA. Extracorporeal shock wave lithotripsy in children: experience using two second-generation lithotripters. BJU Int. 2000;86(7):851–6.

    Article  CAS  PubMed  Google Scholar 

  163. Raza A, Turna B, Smith G, Moussa S, Tolley DA. Pediatric urolithiasis: 15 years of local experience with minimally invasive endourological management of pediatric calculi. J Urol. 2005;174(2):682–5.

    Article  PubMed  Google Scholar 

  164. Charalambous S, Printza N, Papathanasiou A, Rombis V, Goga C, Papachristou F. Shockwave lithotripsy and endourological management of urinary calculi in children: a single-center 10-year experience. J Endourol. 2008;22(9):2169–74.

    Article  CAS  PubMed  Google Scholar 

  165. Hammad FT, Kaya M, Kazim E. Pediatric extracorporeal shockwave lithotripsy: its efficiency at various locations in the upper tract. J Endourol. 2009;23(2):229–35.

    Article  PubMed  Google Scholar 

  166. Preminger GM, Tiselius HG, Assimos DG, Alken P, Buck AC, Gallucci M, et al. Guideline for the management of ureteral calculi. Eur Urol. 2007;52(6):1610–31.

    Article  PubMed  Google Scholar 

  167. Desai MR, Kukreja RA, Patel SH, Bapat SD. Percutaneous nephrolithotomy for complex pediatric renal calculus disease. J Endourol. 2004;18(1):23–7.

    Article  PubMed  Google Scholar 

  168. Alconcher LF, Castro C, Quintana D, Abt N, Moran L, Gonzalez L, et al. Urinary calcium excretion in healthy school children. Pediatr Nephrol. 1997;11(2):186–8.

    Article  CAS  PubMed  Google Scholar 

  169. Sargent JD, Stukel TA, Kresel J, Klein RZ. Normal values for random urinary calcium to creatinine ratios in infancy. J Pediatr. 1993;123(3):393–7.

    Article  CAS  PubMed  Google Scholar 

  170. De Santo NG, Di Iorio B, Capasso G, Paduano C, Stamler R, Langman CB, et al. Population based data on urinary excretion of calcium, magnesium, oxalate, phosphate and uric acid in children from Cimitile (southern Italy). Pediatr Nephrol. 1992;6(2):149–57.

    Article  PubMed  Google Scholar 

  171. Elisaf M, Panteli K, Theodorou J, Siamopoulos KC. Fractional excretion of magnesium in normal subjects and in patients with hypomagnesemia. Magnes Res: Off Organ Int Soc Dev Res Magnes. 1997;10(4):315–20.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Division of Nephrology, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada

    Elizabeth Harvey

  2. Department of Surgery, Division of Urology, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada

    Walid A. Farhat

Authors
  1. Elizabeth Harvey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Walid A. Farhat
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elizabeth Harvey .

Editor information

Editors and Affiliations

  1. Division of Nephrology, The Hospital for Sick Children, Toronto, Ontario, Canada

    Denis F. Geary

  2. Division of Pediatric Nephrology, University of Heidelberg, Heidelberg, Germany

    Franz Schaefer

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Harvey, E., Farhat, W.A. (2016). Renal Calculi. In: Geary, D., Schaefer, F. (eds) Pediatric Kidney Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-52972-0_44

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-52972-0_44

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-52970-6

  • Online ISBN: 978-3-662-52972-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation